Track the latest Incyte insider trading activity. Stay informed on recent buys, sells, and market impact for Incyte stock.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
At Incyte Corp, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 2.05K shares worth $199.66K, meanwhile, insiders have report no purchases in the last 30 days.
Browse insider trades on all stocks.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
| Jun 08, 2026 | Thomas Tray | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $91.91 | -$42.67K | SELL-OPTIONS | 0.00% | 21.13K | Jun 04 | View |
| May 28, 2026 | Thomas Tray | PRINCIPAL ACCOUNTING OFFICER | -2.05K | $97.35 | -$199.66K | SELL | -8.85% | 21.13K | May 26 | View |
| May 21, 2026 | Paul Clancy | DIRECTOR | 0.00 | $89.73 | -$156.00K | SELL-OPTIONS | 0.00% | 23.74K | May 19 | View |
| Apr 21, 2026 | PABLO CAGNONI | PRESIDENT, GLOBAL HEAD R&D | 0.00 | $82.96 | -$505.32K | SELL-OPTIONS | 0.00% | 262.69K | Apr 17 | View |
| Mar 19, 2026 | PABLO CAGNONI | PRESIDENT, R&D | 0.00 | $78.66 | -$581.82K | SELL-OPTIONS | 0.00% | 234.80K | Mar 17 | View |
| Feb 23, 2026 | PABLO CAGNONI | PRESIDENT, R&D | 0.00 | $81.25 | -$734.09K | SELL-OPTIONS | 0.00% | 234.80K | Feb 19 | View |
| Jan 08, 2026 | Khairie Mohamed Issa | EVP, HEAD US ONCOLOGY | -19.12K | $108.03 | -$2.07M | SELL | -22.43% | 66.13K | Jan 06 - Jan 07 | View |
| Jan 07, 2026 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | -15.63K | $101.70 | -$1.59M | SELL | -31.37% | 34.20K | Jan 05 | View |
| Dec 22, 2025 | Thomas Tray | PRINCIPAL ACCOUNTING OFFICER | -600.00 | $97.72 | -$70.71K | SELL | -2.55% | 22.97K | Dec 18 - Dec 19 | View |
| Dec 18, 2025 | James Michael Morrissey | EVP, HEAD TECH. OPERATIONS | -58.33K | $97.29 | -$5.68M | SELL | -67.95% | 27.51K | Dec 16 - Dec 17 | View |
| Dec 12, 2025 | Patrick Mayes | EVP & CHIEF SCIENTIFIC OFFICER | -5.81K | $95.55 | -$554.97K | SELL | -8.82% | 60.01K | Dec 10 - Dec 11 | View |
| Dec 03, 2025 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | -39.76K | $102.34 | -$4.07M | SELL | -38.64% | 63.13K | Dec 01 - Dec 02 | View |
| Nov 25, 2025 | Thomas Tray | PRINCIPAL ACCOUNTING OFFICER | -769.00 | $102.78 | -$79.04K | SELL | -3.16% | 23.57K | Nov 21 - Nov 24 | View |
| Nov 19, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | 0.00 | $84.31 | -$11.15K | SELL-OPTIONS | 0.00% | 26.57K | Nov 17 | View |
| Nov 12, 2025 | Herve Hoppenot | DIRECTOR | -187.50K | $105.46 | -$19.77M | SELL | -36.26% | 329.65K | Nov 10 | View |
| Nov 07, 2025 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | 0.00 | $97.62 | -$47.94K | SELL-OPTIONS | 0.00% | 102.89K | Nov 05 | View |
| Nov 06, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | 0.00 | $79.71 | -$25.89K | SELL-OPTIONS | 0.00% | 26.57K | Nov 04 | View |
| Nov 05, 2025 | Lee Heeson | EVP, HEAD INCYTE INTL | -3.07K | $94.02 | -$289.02K | SELL | -9.51% | 29.24K | Nov 03 | View |
| Oct 17, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | 0.00 | $74.69 | -$5.78K | SELL-OPTIONS | 0.00% | 26.57K | Oct 15 | View |
| Oct 06, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | -6.63K | $72.05 | -$587.26K | SELL | -19.97% | 26.57K | Oct 02 - Oct 03 | View |
| Sep 18, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | 0.00 | $73.70 | -$5.25K | SELL-OPTIONS | 0.00% | 33.20K | Sep 16 | View |
| Sep 04, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | 0.00 | $71.52 | -$16.09K | SELL-OPTIONS | 0.00% | 33.20K | Sep 02 | View |
| Aug 19, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | 0.00 | $75.53 | -$6.25K | SELL-OPTIONS | 0.00% | 33.20K | Aug 15 | View |
| Aug 06, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | 0.00 | $66.92 | -$10.59K | SELL-OPTIONS | 0.00% | 33.20K | Aug 04 | View |
| Jul 23, 2025 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | -3.71K | $67.94 | -$251.79K | SELL | -3.48% | 102.89K | Jul 21 | View |
| Jul 17, 2025 | Barry Flannelly | EVP & GENERAL MANAGER US | -1.34K | $68.36 | -$91.60K | SELL | -3.67% | 35.15K | Jul 16 | View |
| Jul 17, 2025 | Vijay Iyengar | EVP, GMAPPS | -983.00 | $68.36 | -$67.20K | SELL | -2.37% | 40.54K | Jul 16 | View |
| Jul 17, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | 6.70K | $66.82 | -$120.32K | SELL-OPTIONS | 25.26% | 33.20K | Jul 15 - Jul 16 | View |
| Jul 16, 2025 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | -5.83K | $68.58 | -$1.24M | SELL | -5.18% | 106.59K | Jul 14 - Jul 15 | View |
| Jul 16, 2025 | Vijay Iyengar | EVP, GMAPPS | 3.82K | $69.37 | -$180.92K | GRANT | 10.14% | 41.52K | Jul 14 - Jul 15 | View |
| Jul 16, 2025 | Barry Flannelly | EVP & GENERAL MANAGER US | -3.25K | $69.33 | -$225.67K | SELL | -8.19% | 36.49K | Jul 14 - Jul 15 | View |
| Jul 07, 2025 | Barry Flannelly | EVP & GENERAL MANAGER US | -19.96K | $68.16 | -$1.36M | SELL | -33.43% | 39.74K | Jul 02 - Jul 03 | View |
| Jul 07, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | 0.00 | $63.34 | -$6.32K | SELL-OPTIONS | 0.00% | 26.50K | Jul 02 | View |
| Jul 07, 2025 | Vijay Iyengar | EVP, GMAPPS | -15.43K | $68.16 | -$1.05M | SELL | -29.04% | 37.70K | Jul 02 - Jul 03 | View |
| Jun 05, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | 0.00 | $63.03 | -$17.84K | SELL-OPTIONS | 0.00% | 26.50K | Jun 03 | View |
| Jun 03, 2025 | Thomas Tray | PRINCIPAL ACCOUNTING OFFICER | -1.61K | $65.38 | -$105.52K | SELL | -6.83% | 22.00K | May 30 - Jun 02 | View |
| Mar 18, 2025 | Barry Flannelly | EVP & GENERAL MANAGER US | -19.81K | $67.69 | -$1.34M | SELL | -37.11% | 33.57K | Mar 14 | View |
| Mar 06, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | 0.00 | $64.03 | -$7.15K | SELL-OPTIONS | 0.00% | 25.85K | Mar 04 | View |
| Feb 28, 2025 | Sheila Denton | EVP & GENERAL COUNSEL | -4.50K | $66.07 | -$486.27K | SELL | -14.81% | 25.85K | Feb 26 | View |
| Jan 22, 2025 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | -12.35K | $72.69 | -$897.87K | SELL | -15.57% | 66.97K | Jan 21 | View |
| Dec 17, 2024 | Thomas Tray | PRINCIPAL ACCOUNTING OFFICER | -1.30K | $69.97 | -$90.97K | SELL | -5.28% | 23.31K | Dec 13 - Dec 16 | View |
| Dec 03, 2024 | Vijay Iyengar | EVP, GMAPPS | -6.04K | $75.38 | -$455.54K | SELL | -16.47% | 30.66K | Nov 29 | View |
| Nov 08, 2024 | Barry Flannelly | EVP & GENERAL MANAGER US | 0.00 | $74.85 | -$35.49K | SELL-OPTIONS | 0.00% | 58.04K | Nov 06 | View |
| Sep 16, 2024 | Thomas Tray | PRINCIPAL ACCOUNTING OFFICER | -954.00 | $63.11 | -$60.21K | SELL | -3.76% | 24.44K | Sep 12 - Sep 13 | View |
| Sep 16, 2024 | Elliott Jonathan Dickinson | EVP, GENERAL MANAGER, EUROPE | -8.45K | $62.36 | -$526.95K | SELL | -18.84% | 36.39K | Sep 12 | View |
| Aug 14, 2024 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | -11.61K | $60.63 | -$703.79K | SELL | -11.42% | 90.01K | Aug 12 | View |
| Jul 29, 2024 | Vijay Iyengar | EVP, GMAPPS | -15.57K | $70.00 | -$1.09M | SELL | -29.79% | 36.70K | Jul 25 | View |
| Jul 17, 2024 | Barry Flannelly | EVP & GENERAL MANAGER US | 7.51K | $64.22 | -$155.21K | GRANT | 14.86% | 58.04K | Jul 15 - Jul 16 | View |
| Jul 11, 2024 | Barry Flannelly | EVP & GENERAL MANAGER US | -8.15K | $60.00 | -$488.88K | SELL | -13.89% | 50.53K | Jul 09 | View |
| Jun 14, 2024 | Barry Flannelly | EVP & GENERAL MANAGER US | -19.16K | $60.00 | -$1.15M | SELL | -22.40% | 66.38K | Jun 12 | View |
| Jun 10, 2024 | Thomas Tray | PRINCIPAL ACCOUNTING OFFICER | -1.09K | $58.91 | -$64.39K | SELL | -4.81% | 21.63K | Jun 06 | View |
| Jan 05, 2024 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | -7.37K | $65.51 | -$482.48K | SELL | -7.55% | 90.22K | Jan 03 | View |
| Jan 04, 2024 | Vijay Iyengar | EVP, GMAPPS | -657.00 | $65.00 | -$42.70K | SELL | -1.49% | 43.41K | Jan 02 | View |
| Dec 14, 2023 | Thomas Tray | PRINCIPAL ACCOUNTING OFFICER | -1.28K | $61.55 | -$78.59K | SELL | -5.17% | 23.44K | Dec 12 - Dec 13 | View |
| Sep 06, 2023 | PAULA SWAIN | EVP, HUMAN RESOURCES | -8.45K | $65.13 | -$550.28K | SELL | -9.83% | 77.53K | Sep 01 | View |
| Aug 03, 2023 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | -21.51K | $63.28 | -$1.36M | SELL | -18.06% | 97.58K | Aug 01 | View |
| Feb 02, 2023 | Maria Pasquale | EVP & GENERAL COUNSEL | 0.00 | $79.42 | -$7.44K | SELL-OPTIONS | 0.00% | 68.52K | Jan 31 | View |
| Feb 01, 2023 | Maria Pasquale | EVP & GENERAL COUNSEL | 0.00 | $79.07 | -$681.35K | SELL-OPTIONS | 0.00% | 68.52K | Jan 30 | View |
| Jan 30, 2023 | Vijay Iyengar | EVP, GMAPPS | 0.00 | $76.81 | -$114.66K | SELL-OPTIONS | 0.00% | 42.84K | Jan 26 | View |
| Jan 30, 2023 | Dashyant Dhanak | EVP & CHIEF SCIENTIFIC OFFICER | -2.42K | $85.00 | -$205.62K | SELL | -4.34% | 53.26K | Jan 26 | View |
| Jan 06, 2023 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | -28.40K | $79.78 | -$2.27M | SELL | -20.67% | 109.02K | Jan 04 | View |
| Dec 28, 2022 | Vijay Iyengar | EVP, GMAPPS | -2.46K | $75.83 | -$346.28K | SELL | -6.10% | 37.85K | Dec 23 | View |
| Dec 21, 2022 | Thomas Tray | PRINCIPAL ACCOUNTING OFFICER | -1.22K | $82.16 | -$100.48K | SELL | -6.86% | 16.61K | Dec 19 | View |
| Jul 26, 2022 | Thomas Tray | PRINCIPAL ACCOUNTING OFFICER | -1.56K | $83.13 | -$130.02K | SELL | -8.12% | 17.70K | Jul 22 | View |
| Jul 11, 2022 | Vijay Iyengar | EVP, GMAPPS | -5.79K | $79.38 | -$459.37K | SELL | -12.55% | 40.31K | Jul 07 | View |
| Jul 11, 2022 | Barry Flannelly | EVP & GENERAL MANAGER US | -2.87K | $79.38 | -$228.06K | SELL | -3.80% | 72.67K | Jul 07 | View |
| Apr 12, 2022 | Barry Flannelly | EVP & GENERAL MANAGER US | -2.13K | $76.98 | -$722.26K | SELL | -3.16% | 65.16K | Apr 08 | View |
| Mar 10, 2022 | BAKER BROS ADVISORS LP LPJULIAN BAKERBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKER | DIRECTOR | 429.08K | $67.56 | $28.99M | BUY | 1.30% | 33.45M | Mar 08 - Mar 10 | View |
| Feb 22, 2022 | BAKER BROS ADVISORS LP LPJULIAN BAKERBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKER | DIRECTOR | 525.80K | $67.96 | $35.73M | BUY | 1.62% | 33.07M | Feb 17 - Feb 22 | View |
| Feb 14, 2022 | BAKER BROS ADVISORS LP LPJULIAN BAKERBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKER | DIRECTOR | 1.60M | $66.91 | $106.95M | BUY | 4.73% | 35.41M | Feb 10 - Feb 14 | View |
| Feb 02, 2022 | Elliott Jonathan Dickinson | EVP, GENERAL MANAGER, EUROPE | -7.38K | $74.19 | -$547.15K | SELL | -19.62% | 30.21K | Jan 31 | View |
| Jan 11, 2022 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $73.26 | -$1.09K | SELL-OPTIONS | 0.00% | 72.37K | Jan 07 | View |
| Jan 05, 2022 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $73.26 | -$821.40 | SELL-OPTIONS | 0.00% | 32.27K | Jan 03 | View |
| Jan 05, 2022 | Paula Swain | EVP, HUMAN RESOURCES | 8.68K | $73.33 | -$2.33K | SELL-OPTIONS | 13.62% | 72.37K | Jan 01 - Jan 04 | View |
| Dec 27, 2021 | WENDY DIXON | DIRECTOR | 0.00 | $47.65 | $1.02M | SELL-OPTIONS | 0.00% | 17.26K | Dec 23 | View |
| Dec 17, 2021 | BAKER BROS ADVISORS LP LPBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKERJULIAN BAKER | DIRECTOR | 1.60M | $72.43 | $115.56M | BUY | 5.43% | 30.97M | Dec 15 - Dec 17 | View |
| Oct 04, 2021 | Dashyant Dhanak | EVP & CHIEF SCIENTIFIC OFFICER | -389.00 | $68.67 | -$26.71K | SELL | -1.23% | 31.26K | Oct 01 | View |
| Sep 03, 2021 | Dashyant Dhanak | EVP & CHIEF SCIENTIFIC OFFICER | -388.00 | $76.71 | -$29.76K | SELL | -1.21% | 31.65K | Sep 01 | View |
| Aug 04, 2021 | Dashyant Dhanak | EVP & CHIEF SCIENTIFIC OFFICER | -389.00 | $77.49 | -$30.14K | SELL | -1.20% | 32.04K | Aug 02 | View |
| Aug 02, 2021 | Vijay Iyengar | EVP GPS, BD, & LICENSING | -4.91K | $78.29 | -$384.48K | SELL | -15.39% | 27.00K | Jul 29 | View |
| Jul 02, 2021 | Dashyant Dhanak | EVP & CHIEF SCIENTIFIC OFFICER | -396.00 | $84.09 | -$33.30K | SELL | -1.49% | 26.15K | Jul 01 | View |
| Jun 30, 2021 | Wenqing Yao | EVP, HEAD DISCOVERY CHEM | -50.00K | $85.48 | -$4.27M | SELL | -34.70% | 94.08K | Jun 28 - Jun 29 | View |
| Jun 14, 2021 | Dashyant Dhanak | EVP & CHIEF SCIENTIFIC OFFICER | 0.00 | $76.21 | -$82.98K | SELL-OPTIONS | 0.00% | 26.55K | Jun 10 | View |
| Jun 03, 2021 | Dashyant Dhanak | EVP & CHIEF SCIENTIFIC OFFICER | -395.00 | $84.13 | -$33.23K | SELL | -1.47% | 26.55K | Jun 01 | View |
| May 05, 2021 | Dashyant Dhanak | EVP & CHIEF SCIENTIFIC OFFICER | -396.00 | $85.40 | -$33.82K | SELL | -1.45% | 26.94K | May 03 | View |
| Apr 05, 2021 | Dashyant Dhanak | EVP & CHIEF SCIENTIFIC OFFICER | -396.00 | $81.57 | -$32.30K | SELL | -1.43% | 27.34K | Apr 01 | View |
| Mar 31, 2021 | Michael Morrissey | EVP, HEAD TECH. OPERATIONS | -20.00K | $81.08 | -$1.62M | SELL | -30.56% | 45.45K | Mar 29 | View |
| Mar 03, 2021 | Dashyant Dhanak | EVP & CHIEF SCIENTIFIC OFFICER | -395.00 | $79.73 | -$31.49K | SELL | -1.40% | 27.73K | Mar 01 | View |
| Feb 23, 2021 | Herve Hoppenot | CHAIRMAN / CEO | 12.93K | $77.37 | $1.00M | BUY | 3.83% | 350.46K | Feb 23 | View |
| Feb 03, 2021 | Dashyant Dhanak | EVP & CHIEF SCIENTIFIC OFFICER | -395.00 | $77.71 | -$59.17K | SELL | -1.38% | 28.13K | Feb 01 | View |
| Jan 27, 2021 | Wenqing Yao | EVP, HEAD DISCOVERY CHEM | 0.00 | $86.60 | -$577.19K | SELL-OPTIONS | 0.00% | 143.78K | Jan 25 | View |
| Jan 27, 2021 | Steven H Stein | EVP & CHIEF MEDICAL OFFICER | 0.00 | $84.31 | -$119.09K | SELL-OPTIONS | 0.00% | 119.74K | Jan 25 | View |
| Jan 27, 2021 | Vijay Iyengar | EVP GPS, BD, & LICENSING | -1.00K | $85.93 | -$206.59K | SELL | -3.68% | 26.16K | Jan 25 | View |
| Jan 27, 2021 | Barry Flannelly | EVP & GENERAL MANAGER US | -2.74K | $100.00 | -$274.40K | SELL | -5.20% | 49.99K | Jan 25 | View |
| Nov 12, 2020 | JACQUES JEAN BIENAIME | — | -798.00 | $83.00 | -$66.23K | SELL | -8.45% | 8.65K | Nov 10 | View |
| Nov 10, 2020 | Dashyant Dhanak | — | 0.00 | $75.30 | -$18.98K | OPTION EXERCISE | 0.00% | 28.01K | Nov 06 | View |
| Nov 04, 2020 | Barry Flannelly | — | 0.00 | $67.52 | -$763.20K | OPTION EXERCISE | 0.00% | 39.98K | Nov 02 | View |
| Oct 13, 2020 | Maria Pasquale | EVP & GENERAL COUNSEL | 128.00 | $81.68 | -$29.17K | SELL-OPTIONS | 0.45% | 28.46K | Oct 09 - Oct 12 | View |
| Oct 08, 2020 | Dashyant Dhanak | — | 0.00 | $78.69 | -$25.51K | OPTION EXERCISE | 0.00% | 28.01K | Oct 06 | View |
| Sep 14, 2020 | Maria Pasquale | — | 127.00 | $78.09 | -$47.55K | OPTION EXERCISE | 0.45% | 28.33K | Sep 10 - Sep 11 | View |
| Sep 10, 2020 | Dashyant Dhanak | — | 0.00 | $77.18 | -$22.60K | OPTION EXERCISE | 0.00% | 28.01K | Sep 08 | View |
| Aug 31, 2020 | WENDY DIXON | — | 0.00 | $56.74 | -$1.51M | OPTION EXERCISE | 0.00% | 14.24K | Aug 27 | View |
| Aug 10, 2020 | Dashyant Dhanak | — | 0.00 | $81.61 | -$31.12K | OPTION EXERCISE | 0.00% | 28.01K | Aug 06 | View |
| Jul 17, 2020 | Steven Stein | — | -1.39K | $104.02 | -$144.48K | TAX | -1.43% | 95.47K | Jul 15 - Jul 16 | View |
| Jul 08, 2020 | Vijay Iyengar | — | -3.60K | $108.06 | -$388.46K | SELL | -12.18% | 25.93K | Jul 07 - Jul 08 | View |
| Jul 08, 2020 | Steven Stein | — | -3.89K | $99.10 | -$653.06K | OPTION EXERCISE | -3.86% | 96.86K | Jul 07 - Jul 08 | View |
| Jul 07, 2020 | Wenqing Yao | — | 4.07K | $85.89 | -$984.37K | GRANT OR AWARD | 2.67% | 156.26K | Jul 02 - Jul 06 | View |
| Jul 07, 2020 | Steven Stein | — | 2.40K | $91.37 | -$1.52M | GRANT OR AWARD | 2.44% | 100.75K | Jul 02 - Jul 06 | View |
| Jul 07, 2020 | Herve Hoppenot | — | 25.90K | $91.39 | -$4.71M | GRANT OR AWARD | 8.44% | 332.74K | Jul 02 - Jul 07 | View |
| Jul 07, 2020 | Dashyant Dhanak | — | 5.60K | $85.97 | -$152.09K | GRANT OR AWARD | 28.04% | 25.59K | Jul 02 - Jul 06 | View |
| Jun 30, 2020 | Herve Hoppenot | — | 0.00 | $83.73 | -$4.76M | OPTION EXERCISE | 0.00% | 306.84K | Jun 26 | View |
| Jun 25, 2020 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $87.28 | -$315.56K | SELL-OPTIONS | 0.00% | 21.73K | Jun 23 | View |
| Jun 25, 2020 | Barry Flannelly | — | 199.00 | $91.60 | -$147.21 | OPTION EXERCISE | 0.55% | 36.06K | Jun 23 | View |
| Jun 23, 2020 | Maria Pasquale | — | 0.00 | $86.13 | -$39.46K | OPTION EXERCISE | 0.00% | 23.66K | Jun 19 | View |
| Jun 23, 2020 | Vijay Iyengar | — | 0.00 | $88.93 | -$252.81K | OPTION EXERCISE | 0.00% | 24.90K | Jun 19 | View |
| Jun 23, 2020 | Barry Flannelly | — | 0.00 | $89.11 | -$228.28K | OPTION EXERCISE | 0.00% | 35.86K | Jun 19 | View |
| Jun 23, 2020 | Elliott Jonathan Dickinson | — | -9.00K | $105.31 | -$947.79K | SELL | -29.26% | 21.76K | Jun 22 | View |
| Jun 12, 2020 | Maria Pasquale | — | 0.00 | $80.58 | -$100.73K | OPTION EXERCISE | 0.00% | 23.53K | Jun 10 | View |
| Jun 10, 2020 | Dashyant Dhanak | — | 0.00 | $78.65 | -$25.42K | OPTION EXERCISE | 0.00% | 19.99K | Jun 08 | View |
| May 28, 2020 | BAKER BROS ADVISORS LP LPBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKERJULIAN BAKER | — | 2.57K | $102.55 | $205.10 | GRANT OR AWARD | 0.01% | 29.35M | May 26 - May 28 | View |
| May 08, 2020 | Dashyant Dhanak | — | 0.00 | $81.13 | -$30.19K | OPTION EXERCISE | 0.00% | 19.99K | May 06 | View |
| Apr 21, 2020 | Paul Trower | — | 0.00 | $82.28 | -$40.52K | OPTION EXERCISE | 0.00% | 21.32K | Apr 17 | View |
| Apr 21, 2020 | Barry Flannelly | — | 0.00 | $86.60 | -$176.36K | OPTION EXERCISE | 0.00% | 35.34K | Apr 17 | View |
| Apr 20, 2020 | Maria Pasquale | — | 0.00 | $83.97 | -$513.40K | OPTION EXERCISE | 0.00% | 22.90K | Apr 16 - Apr 17 | View |
| Apr 15, 2020 | Maria Pasquale | — | -838.00 | $77.57 | -$513.64K | OPTION EXERCISE | -3.53% | 22.90K | Apr 13 - Apr 14 | View |
| Apr 08, 2020 | Maria Pasquale | — | -1.84K | $85.00 | -$156.57K | SELL | -7.06% | 24.25K | Apr 06 | View |
| Apr 08, 2020 | Dashyant Dhanak | — | 0.00 | $75.21 | -$75.27K | OPTION EXERCISE | 0.00% | 19.99K | Apr 06 | View |
| Apr 02, 2020 | Paula Swain | — | 0.00 | $68.00 | -$16.05K | OPTION EXERCISE | 0.00% | 48.49K | Mar 31 | View |
| Feb 21, 2020 | Paula Swain | — | 0.00 | $72.28 | -$38.63K | OPTION EXERCISE | 0.00% | 48.49K | Feb 19 | View |
| Feb 07, 2020 | Wenqing Yao | — | 0.00 | $47.14 | -$1.01M | OPTION EXERCISE | 0.00% | 95.31K | Feb 05 | View |
| Jan 17, 2020 | Paula Swain | — | 0.00 | $72.84 | -$41.42K | OPTION EXERCISE | 0.00% | 41.61K | Jan 15 | View |
| Dec 18, 2019 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $78.08 | -$67.65K | SELL-OPTIONS | 0.00% | 41.61K | Dec 16 | View |
| Dec 03, 2019 | Wenqing Yao | EVP, HEAD DISCOVERY CHEM | 0.00 | $56.66 | -$1.53M | SELL-OPTIONS | 0.00% | 95.31K | Nov 29 - Dec 02 | View |
| Dec 03, 2019 | Vijay Iyengar | EVP GPS, BD, & LICENSING | 0.00 | $83.93 | -$174.15K | SELL-OPTIONS | 0.00% | 17.61K | Nov 29 - Dec 02 | View |
| Dec 03, 2019 | Barry Flannelly | EVP & GENERAL MANAGER US | 0.00 | $84.10 | -$156.50K | SELL-OPTIONS | 0.00% | 16.98K | Nov 29 - Dec 02 | View |
| Nov 26, 2019 | Barry Flannelly | EVP & GENERAL MANAGER US | 0.00 | $69.22 | -$89.02K | SELL-OPTIONS | 0.00% | 16.98K | Nov 25 | View |
| Nov 26, 2019 | Yao Wenqing | EVP, HEAD DISCOVERY CHEM | 0.00 | $54.16 | -$1.08M | SELL-OPTIONS | 0.00% | 95.31K | Nov 25 | View |
| Nov 26, 2019 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $54.16 | -$1.08M | SELL-OPTIONS | 0.00% | 17.31K | Nov 25 | View |
| Nov 19, 2019 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $75.50 | -$54.77K | SELL-OPTIONS | 0.00% | 41.61K | Nov 15 | View |
| Nov 08, 2019 | WENDY DIXON | DIRECTOR | 0.00 | $48.19 | -$3.81M | SELL-OPTIONS | 0.00% | 12.34K | Nov 06 - Nov 08 | View |
| Nov 05, 2019 | Yao Wenqing | EVP, HEAD DISCOVERY CHEM | 0.00 | $51.66 | -$530.77K | SELL-OPTIONS | 0.00% | 95.31K | Nov 01 | View |
| Nov 05, 2019 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $51.66 | -$566.78K | SELL-OPTIONS | 0.00% | 17.31K | Nov 01 | View |
| Oct 31, 2019 | Wenqing Yao | EVP, HEAD DISCOVERY CHEM | -50.00K | $51.66 | -$136.03K | SELL | -34.41% | 95.31K | Oct 29 - Oct 30 | View |
| Oct 31, 2019 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $49.39 | -$1.03M | SELL-OPTIONS | 0.00% | 17.31K | Oct 29 | View |
| Oct 31, 2019 | Vijay Iyengar | EVP GPS, BD, & LICENSING | -930.00 | $85.00 | -$79.05K | SELL | -5.02% | 17.61K | Oct 29 | View |
| Oct 24, 2019 | PAULA SWAIN | EVP, HUMAN RESOURCES | 0.00 | $72.28 | -$38.63K | SELL-OPTIONS | 0.00% | 41.61K | Oct 22 | View |
| Sep 19, 2019 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $72.28 | -$38.63K | SELL-OPTIONS | 0.00% | 41.61K | Sep 18 | View |
| Sep 19, 2019 | Barry Flannelly | EVP & GENERAL MANAGER US | -2.49K | $77.71 | -$193.58K | SELL | -12.94% | 16.76K | Sep 17 | View |
| Aug 19, 2019 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $72.75 | -$41.02K | SELL-OPTIONS | 0.00% | 41.61K | Aug 15 | View |
| Aug 06, 2019 | PAUL FRIEDMAN | DIRECTOR | 0.00 | $50.50 | -$6.44M | SELL-OPTIONS | 0.00% | 270.53K | Aug 02 - Aug 06 | View |
| Aug 05, 2019 | JACQUES JEAN BIENAIME | DIRECTOR | -1.72K | $85.07 | -$146.65K | SELL | -19.64% | 7.05K | Aug 01 - Aug 02 | View |
| Jul 18, 2019 | Barry Flannelly | EVP & GENERAL MANAGER US | -959.00 | $79.91 | -$76.63K | SELL | -4.75% | 19.25K | Jul 17 | View |
| Jul 16, 2019 | Paula Swain | EVP, HUMAN RESOURCES | -639.00 | $72.42 | -$90.63K | SELL | -1.51% | 41.61K | Jul 15 | View |
| Jun 25, 2019 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | -8.36K | $87.96 | -$735.08K | SELL | -43.61% | 10.80K | Jun 24 | View |
| Jun 18, 2019 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $72.28 | -$38.63K | SELL-OPTIONS | 0.00% | 36.51K | Jun 17 | View |
| Apr 02, 2019 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $52.67 | -$686.90K | SELL-OPTIONS | 0.00% | 36.51K | Apr 01 | View |
| Mar 05, 2019 | PAULA SWAIN | EVP, HUMAN RESOURCES | 0.00 | $52.50 | -$683.60K | SELL-OPTIONS | 0.00% | 36.51K | Mar 01 | View |
| Feb 05, 2019 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $49.75 | -$628.70K | SELL-OPTIONS | 0.00% | 31.12K | Feb 01 | View |
| Jan 30, 2019 | Barry Flannelly | EVP & GENERAL MANAGER US | -1.00K | $80.00 | -$80.00K | SELL | -10.06% | 8.94K | Jan 28 | View |
| Jan 22, 2019 | Yao Wenqing | EVP, HEAD DISCOVERY CHEM | 0.00 | $47.70 | -$918.48K | SELL-OPTIONS | 0.00% | 34.41K | Jan 17 | View |
| Jan 17, 2019 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $46.39 | -$332.56K | SELL-OPTIONS | 0.00% | 13.90K | Jan 15 | View |
| Jan 10, 2019 | Barry Flannelly | EVP & GENERAL MANAGER US | -1.71K | $75.56 | -$129.51K | SELL | -14.70% | 9.94K | Jan 08 | View |
| Jan 08, 2019 | Wenqing Yao | EVP, HEAD DISCOVERY CHEM | -808.00 | $46.37 | -$632.06K | SELL | -2.29% | 34.41K | Jan 07 | View |
| Jan 08, 2019 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | -272.00 | $46.38 | -$545.77K | SELL | -1.92% | 13.90K | Jan 07 | View |
| Jan 08, 2019 | Paula Swain | EVP, HUMAN RESOURCES | -1.20K | $44.24 | -$1.64M | SELL | -3.71% | 31.12K | Jan 04 - Jan 07 | View |
| Nov 09, 2018 | JACQUES JEAN BIENAIME | DIRECTOR | 1.00K | $68.77 | $68.77K | BUY | 17.64% | 6.67K | Nov 08 | View |
| Oct 05, 2018 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $43.89 | -$522.10K | SELL-OPTIONS | 0.00% | 14.17K | Oct 03 | View |
| Oct 05, 2018 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $44.16 | -$516.80K | SELL-OPTIONS | 0.00% | 32.32K | Oct 03 | View |
| Oct 05, 2018 | Barry Flannelly | EVP & GENERAL MANAGER US | -1.00K | $70.00 | -$70.00K | SELL | -7.45% | 12.43K | Oct 03 | View |
| Sep 06, 2018 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $45.77 | -$548.90K | SELL-OPTIONS | 0.00% | 32.32K | Sep 04 | View |
| Aug 22, 2018 | PAULA SWAIN | EVP, HUMAN RESOURCES | 0.00 | $44.16 | -$516.80K | SELL-OPTIONS | 0.00% | 32.32K | Aug 21 | View |
| Jul 11, 2018 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $44.72 | -$527.90K | SELL-OPTIONS | 0.00% | 32.96K | Jul 09 | View |
| Jul 11, 2018 | Vijay Iyengar | EVP GPS, BD, & LICENSING | -606.00 | $71.34 | -$43.23K | SELL | -6.96% | 8.10K | Jul 09 | View |
| May 03, 2018 | Herve Hoppenot | CHAIRMAN / CEO | 15.00K | $60.94 | $914.10K | BUY | 5.73% | 276.69K | May 02 | View |
| May 02, 2018 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $40.11 | -$3.57M | SELL-OPTIONS | 0.00% | 33.37K | Apr 30 | View |
| Feb 22, 2018 | David W Gryska | EXECUTIVE VICE PRESIDENT, CFO | -3.02K | $85.73 | -$259.07K | SELL | -21.60% | 10.97K | Feb 20 - Feb 21 | View |
| Feb 22, 2018 | Reid Huber | EVP, CHIEF SCIENTIFIC OFFICER | -3.02K | $85.72 | -$259.04K | SELL | -7.91% | 35.18K | Feb 20 - Feb 21 | View |
| Jan 09, 2018 | David W Gryska | EXECUTIVE VICE PRESIDENT, CFO | 0.00 | $91.35 | -$101.67K | SELL-OPTIONS | 0.00% | 13.99K | Jan 05 | View |
| Jan 03, 2018 | Vijay Iyengar | EVP GPS, BD, & LICENSING | 0.00 | $85.06 | -$122.00K | SELL-OPTIONS | 0.00% | 8.68K | Jan 02 | View |
| Dec 05, 2017 | Reid Huber | EVP, CHIEF SCIENTIFIC OFFICER | -696.00 | $98.01 | -$68.21K | SELL | -1.79% | 38.20K | Dec 01 | View |
| Nov 20, 2017 | Paul A Friedman | DIRECTOR | -28.51K | $105.24 | -$3.00M | SELL | -9.58% | 269.01K | Nov 16 | View |
| Nov 03, 2017 | David W Gryska | EXECUTIVE VICE PRESIDENT, CFO | -7.83K | $106.79 | -$835.99K | SELL | -35.88% | 13.99K | Nov 01 - Nov 02 | View |
| Sep 20, 2017 | Herve Hoppenot | CHAIRMAN / CEO | -70.50K | $119.45 | -$8.42M | SELL | -19.08% | 299.00K | Sep 18 | View |
| Sep 15, 2017 | Barry Flannelly | EVP & GENERAL MANAGER US | -1.39K | $123.72 | -$171.72K | SELL | -8.58% | 14.78K | Sep 13 - Sep 14 | View |
| Sep 08, 2017 | BAKER BROS ADVISORS LP LP LPFELIX BAKERJULIAN BAKERBaker Bros Advisors GP LLCBaker Brothers Life Sciences LP | DIRECTOR | 100.00K | $132.00 | $13.20M | BUY | 13.83% | 822.83K | Sep 08 | View |
| Sep 07, 2017 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $78.10 | -$361.86K | SELL-OPTIONS | 0.00% | 11.85K | Sep 05 | View |
| Sep 05, 2017 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $100.97 | -$132.59K | SELL-OPTIONS | 0.00% | 21.73K | Sep 01 | View |
| Sep 05, 2017 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $78.89 | -$2.44M | SELL-OPTIONS | 0.00% | 35.07K | Aug 31 | View |
| Aug 31, 2017 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | 0.00 | $107.26 | -$74.90K | SELL-OPTIONS | 0.00% | 18.16K | Aug 29 | View |
| Aug 07, 2017 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | -295.00 | $71.55 | -$359.54K | SELL | -2.43% | 11.85K | Aug 03 - Aug 04 | View |
| Aug 03, 2017 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $98.73 | -$124.43K | SELL-OPTIONS | 0.00% | 21.73K | Aug 01 | View |
| Jul 21, 2017 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | 0.00 | $108.39 | -$294.48K | SELL-OPTIONS | 0.00% | 18.16K | Jul 20 | View |
| Jul 07, 2017 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | 1.20K | $71.98 | -$325.17K | SELL-OPTIONS | 10.94% | 12.15K | Jul 05 | View |
| Jul 05, 2017 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $95.38 | -$112.20K | SELL-OPTIONS | 0.00% | 18.22K | Jul 03 | View |
| Jul 05, 2017 | David W Gryska | EXECUTIVE VICE PRESIDENT, CFO | 0.00 | $101.47 | -$33.86K | SELL-OPTIONS | 0.00% | 19.02K | Jun 30 | View |
| Jun 22, 2017 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | 0.00 | $108.23 | -$331.55K | SELL-OPTIONS | 0.00% | 14.65K | Jun 20 | View |
| Jun 14, 2017 | David W Gryska | EXECUTIVE VICE PRESIDENT, CFO | 0.00 | $94.91 | -$727.04K | SELL-OPTIONS | 0.00% | 19.02K | Jun 12 | View |
| Jun 07, 2017 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $75.14 | -$344.13K | SELL-OPTIONS | 0.00% | 10.95K | Jun 05 | View |
| Jun 02, 2017 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $97.28 | -$119.12K | SELL-OPTIONS | 0.00% | 16.92K | Jun 01 | View |
| Jun 02, 2017 | JACQUES JEAN BIENAIME | DIRECTOR | 500.00 | $131.80 | $65.90K | BUY | 11.97% | 4.68K | May 31 | View |
| May 17, 2017 | JACQUES JEAN BIENAIME | DIRECTOR | 500.00 | $115.00 | $57.50K | BUY | 13.60% | 4.18K | May 15 | View |
| May 09, 2017 | Reid Huber | EVP, CHIEF SCIENTIFIC OFFICER | -16.31K | $121.96 | -$1.99M | SELL | -31.16% | 36.04K | May 05 - May 08 | View |
| May 09, 2017 | Paul Trower | PRINCIPAL ACCOUNTING OFFICER | 0.00 | $69.75 | -$311.73K | SELL-OPTIONS | 0.00% | 10.95K | May 05 | View |
| May 02, 2017 | Barry Flannelly | EVP & GENERAL MANAGER US | -3.23K | $86.58 | -$560.58K | SELL | -20.35% | 12.65K | May 01 | View |
| May 02, 2017 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $94.64 | -$109.53K | SELL-OPTIONS | 0.00% | 16.92K | May 01 | View |
| May 02, 2017 | David W Gryska | EXECUTIVE VICE PRESIDENT, CFO | 0.00 | $95.66 | -$79.45K | SELL-OPTIONS | 0.00% | 19.02K | Apr 28 | View |
| May 02, 2017 | JACQUES JEAN BIENAIME | DIRECTOR | 500.00 | $124.26 | $62.13K | BUY | 15.74% | 3.68K | Apr 28 | View |
| Apr 17, 2017 | JACQUES JEAN BIENAIME | DIRECTOR | 1.00K | $139.66 | $139.66K | BUY | 45.93% | 3.18K | Apr 13 | View |
| Apr 11, 2017 | Steven Stein | EVP & CHIEF MEDICAL OFFICER | 0.00 | $113.84 | -$1.54M | SELL-OPTIONS | 0.00% | 14.65K | Apr 07 | View |
| Apr 11, 2017 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $89.66 | -$408.54K | SELL-OPTIONS | 0.00% | 16.79K | Apr 10 | View |
| Apr 11, 2017 | David W Gryska | EXECUTIVE VICE PRESIDENT, CFO | 0.00 | $102.53 | -$2.95M | SELL-OPTIONS | 0.00% | 19.02K | Apr 10 | View |
| Apr 11, 2017 | JACQUES JEAN BIENAIME | DIRECTOR | 1.00K | $139.48 | $139.48K | BUY | 84.96% | 2.18K | Apr 07 | View |
| Mar 20, 2017 | PAUL BROOKE | DIRECTOR | 0.00 | $77.50 | -$2.81M | SELL-OPTIONS | 0.00% | 196.76K | Mar 17 | View |
| Mar 20, 2017 | Paul A Friedman | DIRECTOR | 0.00 | $83.52 | -$6.52M | SELL-OPTIONS | 0.00% | 297.52K | Mar 16 - Mar 17 | View |
| Mar 01, 2017 | Reid Huber | EVP, CHIEF SCIENTIFIC OFFICER | -2.01K | $131.88 | -$264.82K | SELL | -3.70% | 52.26K | Feb 27 | View |
| Feb 27, 2017 | Paul A Friedman | DIRECTOR | 0.00 | $69.32 | -$5.10M | SELL-OPTIONS | 0.00% | 297.52K | Feb 23 | View |
| Jan 11, 2017 | Reid Huber | EVP, CHIEF SCIENTIFIC OFFICER | -11.74K | $113.55 | -$1.33M | SELL | -18.36% | 52.19K | Jan 09 | View |
| Nov 17, 2016 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $58.99 | -$885.40K | SELL-OPTIONS | 0.00% | 29.25K | Nov 15 | View |
| Nov 10, 2016 | Reid Huber | EVP, CHIEF SCIENTIFIC OFFICER | -2.71K | $109.95 | -$298.51K | SELL | -4.07% | 63.92K | Nov 09 | View |
| Oct 24, 2016 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $52.36 | -$752.80K | SELL-OPTIONS | 0.00% | 29.25K | Oct 20 | View |
| Oct 11, 2016 | Reid Huber | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $57.36 | -$914.24K | SELL-OPTIONS | 0.00% | 66.60K | Oct 07 | View |
| Oct 11, 2016 | Barry Flannelly | EVP & GENERAL MANAGER US | 0.00 | $72.72 | -$1.18M | SELL-OPTIONS | 0.00% | 11.19K | Oct 07 | View |
| Sep 26, 2016 | PAULA SWAIN | EVP, HUMAN RESOURCES | 0.00 | $52.36 | -$1.51M | SELL-OPTIONS | 0.00% | 29.25K | Sep 23 | View |
| Aug 02, 2016 | Reid Huber | EVP, CHIEF SCIENTIFIC OFFICER | -10.00K | $87.96 | -$879.60K | SELL | -13.05% | 66.60K | Aug 02 | View |
| Aug 02, 2016 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $52.36 | -$4.52M | SELL-OPTIONS | 0.00% | 29.25K | Jul 29 | View |
| Mar 17, 2016 | JULIAN BAKERFELIX BAKERBAKER BROS ADVISORS LP LPBaker Brothers Life Sciences LP LPBaker Bros Advisors GP LLC | DIRECTOR | 860.00K | $59.79 | $51.42M | BUY | 4.43% | 20.27M | Mar 15 - Mar 17 | View |
| Feb 26, 2016 | JULIAN BAKERFELIX BAKERBAKER BROS ADVISORS LP LPBaker Brothers Life Sciences LP LPBaker Bros Advisors GP LLC | DIRECTOR | 64.29K | $70.79 | $4.55M | BUY | 0.33% | 19.53M | Feb 24 - Feb 25 | View |
| Feb 16, 2016 | JULIAN BAKERFELIX BAKERBAKER BROS ADVISORS LP LPBaker Brothers Life Sciences LP LPBaker Bros Advisors GP LLC | DIRECTOR | 887.16K | $69.87 | $61.98M | BUY | 4.77% | 19.47M | Feb 12 - Feb 16 | View |
| Feb 16, 2016 | JULIAN BAKERFELIX BAKERBAKER BROS ADVISORS LP LPBaker Brothers Life Sciences LP LPBaker Bros Advisors GP LLC | DIRECTOR | 2.25M | $63.53 | $143.03M | BUY | 13.71% | 18.67M | Feb 11 - Feb 12 | View |
| Jan 20, 2016 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $40.03 | -$999.26K | SELL-OPTIONS | 0.00% | 23.69K | Jan 15 | View |
| Jan 08, 2016 | Richard Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $60.09 | -$328.90K | SELL-OPTIONS | 0.00% | 16.93K | Jan 06 | View |
| Dec 14, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $63.14 | -$173.54K | SELL-OPTIONS | 0.00% | 3.71K | Dec 10 | View |
| Dec 09, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $62.25 | -$345.90K | SELL-OPTIONS | 0.00% | 16.93K | Dec 07 | View |
| Nov 19, 2015 | Paul A Friedman | DIRECTOR | 0.00 | $65.81 | -$21.61M | SELL-OPTIONS | 0.00% | 297.52K | Nov 17 - Nov 18 | View |
| Nov 12, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $61.59 | -$192.29K | SELL-OPTIONS | 0.00% | 3.71K | Nov 10 | View |
| Nov 10, 2015 | Richard Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $67.42 | -$386.48K | SELL-OPTIONS | 0.00% | 16.93K | Nov 06 | View |
| Nov 05, 2015 | Wenqing Yao | EVP, DISCOVERY MEDICINAL AND P | -786.00 | $71.28 | -$633.01K | SELL | -3.55% | 21.37K | Nov 03 | View |
| Oct 15, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $59.91 | -$184.80K | SELL-OPTIONS | 0.00% | 3.35K | Oct 13 | View |
| Oct 08, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $70.31 | -$409.33K | SELL-OPTIONS | 0.00% | 16.93K | Oct 06 | View |
| Sep 23, 2015 | Reid Huber | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $71.31 | -$1.06M | SELL-OPTIONS | 0.00% | 62.87K | Sep 21 | View |
| Sep 18, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $74.50 | -$249.69K | SELL-OPTIONS | 0.00% | 3.35K | Sep 16 | View |
| Sep 15, 2015 | Richard Levy | EVP, CHIEF DRUG DEV OFFICER | -4.30K | $130.00 | -$559.13K | SELL | -20.26% | 16.93K | Sep 11 | View |
| Sep 10, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $68.61 | -$395.98K | SELL-OPTIONS | 0.00% | 21.23K | Sep 08 | View |
| Aug 17, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $63.01 | -$198.58K | SELL-OPTIONS | 0.00% | 3.35K | Aug 13 | View |
| Aug 10, 2015 | Richard Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $65.14 | -$368.53K | SELL-OPTIONS | 0.00% | 21.23K | Aug 06 | View |
| Jul 16, 2015 | Wenqing Yao | EVP, DISCOVERY MEDICINAL AND P | 0.00 | $66.31 | -$1.30M | SELL-OPTIONS | 0.00% | 21.54K | Jul 14 - Jul 15 | View |
| Jul 16, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $65.97 | -$211.73K | SELL-OPTIONS | 0.00% | 3.35K | Jul 14 | View |
| Jul 16, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $68.89 | -$7.18M | SELL-OPTIONS | 0.00% | 21.23K | Jul 15 | View |
| Jul 08, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $62.66 | -$349.13K | SELL-OPTIONS | 0.00% | 21.23K | Jul 06 | View |
| Jun 25, 2015 | James Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $64.64 | -$1.02M | SELL-OPTIONS | 0.00% | 3.52K | Jun 23 | View |
| Jun 23, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $62.96 | -$1.81M | SELL-OPTIONS | 0.00% | 21.23K | Jun 19 | View |
| Jun 16, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $61.81 | -$193.38K | SELL-OPTIONS | 0.00% | 3.35K | Jun 12 | View |
| Jun 10, 2015 | Richard Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $62.95 | -$351.42K | SELL-OPTIONS | 0.00% | 21.23K | Jun 08 | View |
| May 28, 2015 | Paul A Friedman | DIRECTOR | 0.00 | $60.97 | -$18.20M | SELL-OPTIONS | 0.00% | 297.52K | May 26 - May 27 | View |
| May 28, 2015 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $63.65 | -$1.03M | SELL-OPTIONS | 0.00% | 3.52K | May 26 | View |
| May 26, 2015 | Paul A Friedman | DIRECTOR | 0.00 | $61.47 | -$9.56M | SELL-OPTIONS | 0.00% | 297.52K | May 21 - May 22 | View |
| May 15, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $61.66 | -$192.58K | SELL-OPTIONS | 0.00% | 3.35K | May 14 | View |
| May 08, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $58.88 | -$601.19K | SELL-OPTIONS | 0.00% | 21.23K | May 06 | View |
| Apr 24, 2015 | James Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $71.82 | -$2.65M | SELL-OPTIONS | 0.00% | 3.52K | Apr 23 | View |
| Apr 21, 2015 | Wenqing Yao | EVP, DISCOVERY MEDICINAL AND P | -7.15K | $102.04 | -$729.59K | SELL | -24.92% | 21.54K | Apr 17 | View |
| Apr 16, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $58.52 | -$178.65K | SELL-OPTIONS | 0.00% | 3.35K | Apr 14 | View |
| Apr 14, 2015 | PAULA SWAIN | EVP, HUMAN RESOURCES | 0.00 | $49.70 | -$1.53M | SELL-OPTIONS | 0.00% | 21.08K | Apr 13 | View |
| Apr 14, 2015 | Wenqing Yao | EVP, DISCOVERY MEDICINAL AND P | 0.00 | $56.49 | -$1.78M | SELL-OPTIONS | 0.00% | 28.69K | Apr 10 - Apr 13 | View |
| Apr 08, 2015 | Wenqing Yao | EVP, DISCOVERY MEDICINAL AND P | -15.03K | $53.96 | -$1.72M | SELL | -34.38% | 28.69K | Apr 07 | View |
| Apr 08, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $53.55 | -$1.76M | SELL-OPTIONS | 0.00% | 21.23K | Apr 06 | View |
| Apr 01, 2015 | Laurent Chardonnet | — | 0.00 | $55.12 | -$8.76M | SELL-OPTIONS | 0.00% | 2.90K | Mar 30 | View |
| Apr 01, 2015 | Reid Huber | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $55.86 | -$2.59M | SELL-OPTIONS | 0.00% | 44.41K | Mar 30 | View |
| Mar 18, 2015 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $46.54 | -$1.52M | SELL-OPTIONS | 0.00% | 21.08K | Mar 16 | View |
| Mar 13, 2015 | BARRY ARIKO | DIRECTOR | 0.00 | $47.61 | -$6.66M | SELL-OPTIONS | 0.00% | 45.83K | Mar 12 | View |
| Mar 13, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $54.02 | -$158.64K | SELL-OPTIONS | 0.00% | 3.35K | Mar 12 | View |
| Mar 10, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV OFFICER | 0.00 | $54.11 | -$1.79M | SELL-OPTIONS | 0.00% | 21.23K | Mar 06 | View |
| Mar 09, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $54.16 | -$955.71K | SELL-OPTIONS | 0.00% | 3.35K | Mar 05 | View |
| Mar 09, 2015 | RICHARD SCHUTTER DE | DIRECTOR | 0.00 | $54.12 | -$3.04M | SELL-OPTIONS | 0.00% | 92.29K | Mar 05 | View |
| Feb 25, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $51.66 | -$889.04K | SELL-OPTIONS | 0.00% | 3.35K | Feb 25 | View |
| Feb 25, 2015 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $49.62 | -$723.86K | SELL-OPTIONS | 0.00% | 3.52K | Feb 23 - Feb 24 | View |
| Feb 20, 2015 | Barry M. Ariko | DIRECTOR | 0.00 | $43.06 | -$1.42M | SELL-OPTIONS | 0.00% | 45.83K | Feb 18 | View |
| Feb 18, 2015 | PAUL FRIEDMAN | DIRECTOR | -120.00K | $74.32 | -$8.92M | SELL | -28.74% | 297.52K | Feb 13 | View |
| Feb 18, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $46.28 | -$734.85K | SELL-OPTIONS | 0.00% | 18.20K | Feb 17 | View |
| Feb 18, 2015 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $40.01 | -$1.29M | SELL-OPTIONS | 0.00% | 21.08K | Feb 17 | View |
| Feb 10, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $46.72 | -$1.42M | SELL-OPTIONS | 0.00% | 18.20K | Feb 06 | View |
| Jan 26, 2015 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $47.36 | -$673.59K | SELL-OPTIONS | 0.00% | 3.52K | Jan 23 | View |
| Jan 26, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $48.82 | -$840.35K | SELL-OPTIONS | 0.00% | 3.35K | Jan 22 - Jan 26 | View |
| Jan 20, 2015 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $38.64 | -$1.24M | SELL-OPTIONS | 0.00% | 21.08K | Jan 20 | View |
| Jan 20, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $43.89 | -$700.20K | SELL-OPTIONS | 0.00% | 18.20K | Jan 16 | View |
| Jan 12, 2015 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $45.89 | -$909.76K | SELL-OPTIONS | 0.00% | 3.35K | Jan 08 | View |
| Jan 08, 2015 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $45.08 | -$1.34M | SELL-OPTIONS | 0.00% | 18.20K | Jan 06 | View |
| Jan 07, 2015 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $38.51 | -$1.24M | SELL-OPTIONS | 0.00% | 18.06K | Jan 05 | View |
| Dec 29, 2014 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $45.74 | -$637.72K | SELL-OPTIONS | 0.00% | 0.00 | Dec 23 | View |
| Dec 18, 2014 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $43.54 | -$691.68K | SELL-OPTIONS | 0.00% | 18.20K | Dec 16 | View |
| Dec 03, 2014 | Richard U. De Schutter | DIRECTOR | -50.00K | $74.89 | -$3.74M | SELL | -32.26% | 105.00K | Dec 01 - Dec 02 | View |
| Nov 26, 2014 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $45.56 | -$633.72K | SELL-OPTIONS | 0.00% | 0.00 | Nov 24 | View |
| Nov 19, 2014 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $42.34 | -$663.00K | SELL-OPTIONS | 0.00% | 18.20K | Nov 17 | View |
| Nov 07, 2014 | Paul A Friedman | DIRECTOR | 0.00 | $38.95 | -$10.74M | SELL-OPTIONS | 0.00% | 417.52K | Nov 06 | View |
| Oct 24, 2014 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $35.27 | -$404.94K | SELL-OPTIONS | 0.00% | 0.00 | Oct 23 | View |
| Oct 20, 2014 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $31.88 | -$274.48K | SELL-OPTIONS | 0.00% | 4.30K | Oct 16 | View |
| Sep 25, 2014 | James Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $32.35 | -$340.05K | SELL-OPTIONS | 0.00% | 0.00 | Sep 23 | View |
| Sep 18, 2014 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $31.15 | -$262.88K | SELL-OPTIONS | 0.00% | 4.30K | Sep 16 | View |
| Aug 27, 2014 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $34.50 | -$387.94K | SELL-OPTIONS | 0.00% | 0.00 | Aug 25 | View |
| Aug 19, 2014 | Richard Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $33.34 | -$298.00K | SELL-OPTIONS | 0.00% | 4.30K | Aug 18 | View |
| Jul 25, 2014 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $32.79 | -$349.94K | SELL-OPTIONS | 0.00% | 0.00 | Jul 23 | View |
| Jul 18, 2014 | Richard Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $31.43 | -$267.44K | SELL-OPTIONS | 0.00% | 4.30K | Jul 16 | View |
| Jun 25, 2014 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $36.54 | -$433.22K | SELL-OPTIONS | 0.00% | 0.00 | Jun 23 | View |
| Jun 18, 2014 | Richard Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $34.30 | -$313.28K | SELL-OPTIONS | 0.00% | 4.30K | Jun 16 | View |
| Jun 06, 2014 | David C Hastings | CHIEF FINANCIAL OFFICER | 0.00 | $30.58 | -$8.86M | SELL-OPTIONS | 0.00% | 8.50K | Jun 04 - Jun 05 | View |
| May 28, 2014 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $32.76 | -$349.27K | SELL-OPTIONS | 0.00% | 0.00 | May 23 | View |
| May 20, 2014 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $32.70 | -$287.68K | SELL-OPTIONS | 0.00% | 4.30K | May 16 | View |
| May 14, 2014 | Laurent Chardonnet | — | -2.06K | $54.00 | -$111.13K | SELL | -54.00% | 1.75K | May 12 | View |
| May 06, 2014 | Laurent Chardonnet | — | 0.00 | $30.48 | -$1.43M | SELL-OPTIONS | 0.00% | 3.81K | May 02 | View |
| Apr 25, 2014 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $32.32 | -$940.51K | SELL-OPTIONS | 0.00% | 0.00 | Apr 23 | View |
| Feb 21, 2014 | Paul A Friedman | DIRECTOR | 0.00 | $33.31 | -$2.01M | SELL-OPTIONS | 0.00% | 417.52K | Feb 20 | View |
| Feb 19, 2014 | Richard U De Schutter | DIRECTOR | 0.00 | $37.21 | -$2.83M | SELL-OPTIONS | 0.00% | 155.00K | Feb 18 - Feb 19 | View |
| Feb 19, 2014 | Paul A Friedman | DIRECTOR | 0.00 | $36.65 | -$44.72M | SELL-OPTIONS | 0.00% | 417.52K | Feb 14 - Feb 19 | View |
| Feb 18, 2014 | BARRY ARIKO | DIRECTOR | 0.00 | $36.75 | -$594.70K | SELL-OPTIONS | 0.00% | 45.83K | Feb 13 | View |
| Feb 18, 2014 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $38.64 | -$12.19M | SELL-OPTIONS | 0.00% | 18.06K | Feb 13 | View |
| Feb 18, 2014 | Eric Siegel | EVP, GENERAL COUNSEL | -1.19K | $41.97 | -$2.79M | SELL | -100.00% | 0.00 | Feb 13 | View |
| Feb 18, 2014 | Laurent Chardonnet | — | 0.00 | $37.76 | -$5.61M | SELL-OPTIONS | 0.00% | 3.19K | Feb 13 | View |
| Feb 18, 2014 | DAVID HASTINGS | CHIEF FINANCIAL OFFICER | 0.00 | $39.43 | -$14.54M | SELL-OPTIONS | 0.00% | 8.50K | Feb 13 - Feb 18 | View |
| Feb 18, 2014 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $37.56 | -$13.30M | SELL-OPTIONS | 0.00% | 4.30K | Feb 13 - Feb 14 | View |
| Feb 18, 2014 | James M Daly | EVP, CHIEF COMMERCIAL OFFICER | 0.00 | $41.73 | -$7.84M | SELL-OPTIONS | 0.00% | 0.00 | Feb 13 | View |
| Nov 20, 2013 | Roy A Whitfield | DIRECTOR | -50.00K | $47.37 | -$2.37M | SELL | -7.45% | 621.08K | Nov 18 | View |
| Sep 12, 2013 | Paul A Friedman | CHIEF EXECUTIVE OFFICER | 0.00 | $22.59 | -$11.10M | SELL-OPTIONS | 0.00% | 391.87K | Sep 10 | View |
| Sep 09, 2013 | Laurent Chardonnet | — | -3.03K | $22.94 | -$1.32M | SELL | -60.00% | 2.02K | Sep 05 - Sep 09 | View |
| Sep 09, 2013 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $21.08 | -$2.64M | SELL-OPTIONS | 0.00% | 18.06K | Sep 05 | View |
| Sep 09, 2013 | David C Hastings | CHIEF FINANCIAL OFFICER | 0.00 | $21.13 | -$2.81M | SELL-OPTIONS | 0.00% | 8.50K | Sep 06 | View |
| Sep 09, 2013 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $26.06 | -$1.02M | SELL-OPTIONS | 0.00% | 899.00 | Sep 06 | View |
| Sep 09, 2013 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $23.63 | -$582.50K | SELL-OPTIONS | 0.00% | 0.00 | Sep 06 | View |
| Aug 20, 2013 | ROY WHITFIELD | DIRECTOR | -50.00K | $26.70 | -$1.33M | SELL | -6.93% | 671.08K | Aug 19 | View |
| May 21, 2013 | Roy A Whitfield | DIRECTOR | -40.00K | $23.08 | -$923.20K | SELL | -5.26% | 721.08K | May 17 | View |
| May 15, 2013 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 4.30K | $14.70 | -$816.69K | SELL-OPTIONS | ∞ | 4.30K | May 13 | View |
| Mar 18, 2013 | Roy A Whitfield | DIRECTOR | -10.00K | $25.08 | -$250.80K | SELL | -1.30% | 761.08K | Mar 14 | View |
| Mar 05, 2013 | Roy A Whitfield | DIRECTOR | -10.00K | $22.56 | -$225.60K | SELL | -1.28% | 771.08K | Mar 01 | View |
| Mar 01, 2013 | Eric Siegel | EVP, GENERAL COUNSEL | 0.00 | $18.91 | -$325.09K | SELL-OPTIONS | 0.00% | 280.00 | Feb 28 | View |
| Feb 22, 2013 | Paula Swain | EVP, HUMAN RESOURCES | 206.57K | $13.76 | $2.84M | SELL-OPTIONS | ∞ | 18.06K | Feb 20 | View |
| Feb 20, 2013 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $14.66 | -$1.54M | SELL-OPTIONS | 0.00% | 0.00 | Feb 15 | View |
| Feb 20, 2013 | David C Hastings | CHIEF FINANCIAL OFFICER | 0.00 | $14.55 | -$1.59M | SELL-OPTIONS | 0.00% | 8.50K | Feb 15 | View |
| Feb 20, 2013 | Roy A Whitfield | DIRECTOR | -30.00K | $21.82 | -$654.60K | SELL | -3.70% | 781.08K | Feb 19 | View |
| Dec 19, 2012 | RICHARD SCHUTTER DE | DIRECTOR | -5.00K | $16.07 | -$76.55K | SELL | -2.47% | 197.71K | Dec 17 | View |
| Jul 06, 2012 | Laurent Chardonnet | — | 0.00 | $16.10 | -$643.29K | SELL-OPTIONS | 0.00% | 3.03K | Jul 05 | View |
| Jul 03, 2012 | Laurent Chardonnet | — | 0.00 | $15.55 | -$630.66K | SELL-OPTIONS | 0.00% | 3.03K | Jul 02 | View |
| May 25, 2012 | Roy A Whitfield | DIRECTOR | -22.00K | $22.27 | -$445.40K | SELL | -2.61% | 821.08K | May 23 - May 24 | View |
| May 18, 2012 | Paul A Brooke | DIRECTOR | 0.00 | $15.11 | -$84.45K | SELL-OPTIONS | 0.00% | 100.00K | May 16 | View |
| May 15, 2012 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $15.91 | -$2.16M | SELL-OPTIONS | 0.00% | 18.06K | May 11 | View |
| May 15, 2012 | Eric Siegel | EVP, GENERAL COUNSEL | -815.00 | $19.60 | -$417.23K | SELL | -100.00% | 0.00 | May 14 | View |
| May 08, 2012 | Paul A Friedman | CHIEF EXECUTIVE OFFICER | 0.00 | $14.26 | -$3.73M | SELL-OPTIONS | 0.00% | 309.71K | May 07 | View |
| May 01, 2012 | Laurent Chardonnet | — | -13.98K | $22.70 | -$317.26K | SELL | -93.14% | 1.03K | May 01 | View |
| May 01, 2012 | Richard Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $15.86 | -$425.55K | SELL-OPTIONS | 0.00% | 0.00 | Apr 27 | View |
| Feb 21, 2012 | Roy A Whitfield | DIRECTOR | -20.00K | $17.53 | -$350.66K | SELL | -2.46% | 793.08K | Feb 17 | View |
| Jan 20, 2012 | Paul A Brooke | DIRECTOR | 50.00K | $17.70 | $884.75K | BUY | 50.00% | 150.00K | Jan 18 - Jan 19 | View |
| Jan 17, 2012 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 14.63K | $16.37 | $239.41K | BUY | 4.29% | 355.84K | Jan 12 - Jan 13 | View |
| Jan 17, 2012 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 543.24K | $16.37 | $8.89M | BUY | 4.57% | 12.43M | Jan 12 - Jan 13 | View |
| Dec 12, 2011 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 403.52K | $13.37 | $5.39M | BUY | 3.51% | 11.89M | Dec 08 - Dec 09 | View |
| Dec 12, 2011 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 10.83K | $13.37 | $144.74K | BUY | 3.28% | 341.21K | Dec 08 - Dec 09 | View |
| Dec 07, 2011 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 41.62K | $13.75 | $572.10K | BUY | 14.41% | 330.39K | Dec 05 - Dec 07 | View |
| Dec 07, 2011 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 1.56M | $13.75 | $21.38M | BUY | 15.66% | 11.48M | Dec 05 - Dec 07 | View |
| Dec 01, 2011 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 51.27K | $13.04 | $668.78K | BUY | 21.59% | 288.77K | Nov 29 - Dec 01 | View |
| Dec 01, 2011 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 2.41M | $13.13 | $31.59M | BUY | 31.99% | 9.93M | Nov 29 - Dec 01 | View |
| Nov 21, 2011 | Wendy L Dixon | DIRECTOR | 7.50K | $13.40 | $100.50K | BUY | ∞ | 7.50K | Nov 17 | View |
| Jun 23, 2011 | Laurent Chardonnet | — | 0.00 | $12.03 | -$525.99K | SELL-OPTIONS | 0.00% | 13.98K | Jun 21 | View |
| Jun 17, 2011 | Roy A Whitfield | DIRECTOR | -20.00K | $18.02 | -$360.45K | SELL | -2.40% | 813.08K | Jun 16 - Jun 17 | View |
| Jun 10, 2011 | David C Hastings | CHIEF FINANCIAL OFFICER | 0.00 | $11.43 | -$1.26M | SELL-OPTIONS | 0.00% | 8.50K | Jun 09 | View |
| May 19, 2011 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $16.55 | -$412.64K | SELL-OPTIONS | 0.00% | 18.06K | May 17 | View |
| May 13, 2011 | Roy A Whitfield | DIRECTOR | -20.00K | $20.16 | -$403.12K | SELL | -2.34% | 833.08K | May 11 - May 12 | View |
| May 11, 2011 | Patricia Schreck | EVP, GENERAL COUNSEL | -100.00K | $10.73 | -$1.99M | SELL | -95.69% | 4.50K | May 09 - May 10 | View |
| May 09, 2011 | Roy A Whitfield | DIRECTOR | -20.00K | $19.51 | -$390.21K | SELL | -2.29% | 853.08K | May 05 - May 09 | View |
| May 09, 2011 | Laurent Chardonnet | — | -5.34K | $19.55 | -$104.46K | SELL | -27.66% | 13.98K | May 06 | View |
| Apr 13, 2011 | Brian W Metcalf | CHIEF DRUG DISCOVERY SCIENTIST | 0.00 | $11.44 | -$1.20M | SELL-OPTIONS | 0.00% | 66.50K | Apr 11 | View |
| Apr 08, 2011 | Patricia Schreck | EVP, GENERAL COUNSEL | 0.00 | $10.16 | -$1.27M | SELL-OPTIONS | 0.00% | 4.50K | Apr 07 | View |
| Apr 08, 2011 | Laurent Chardonnet | — | 0.00 | $10.06 | -$347.38K | SELL-OPTIONS | 0.00% | 11.32K | Apr 08 | View |
| Apr 07, 2011 | Roy A Whitfield | DIRECTOR | -10.00K | $16.01 | -$160.15K | SELL | -1.13% | 873.08K | Apr 05 | View |
| Mar 25, 2011 | Roy A Whitfield | DIRECTOR | -10.00K | $14.65 | -$146.53K | SELL | -1.12% | 883.08K | Mar 25 | View |
| Mar 18, 2011 | Brian W Metcalf | CHIEF DRUG DISCOVERY SCIENTIST | 0.00 | $12.06 | -$927.33K | SELL-OPTIONS | 0.00% | 66.50K | Mar 16 - Mar 18 | View |
| Feb 22, 2011 | Brian W Metcalf | CHIEF DRUG DISCOVERY SCIENTIST | 0.00 | $10.16 | -$419.00K | SELL-OPTIONS | 0.00% | 66.50K | Feb 17 | View |
| Jan 20, 2011 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $11.25 | -$366.71K | SELL-OPTIONS | 0.00% | 0.00 | Jan 18 | View |
| Dec 23, 2010 | Roy A Whitfield | DIRECTOR | -20.00K | $17.01 | -$340.23K | SELL | -2.18% | 896.08K | Dec 22 - Dec 23 | View |
| Nov 18, 2010 | Roy A Whitfield | DIRECTOR | -11.00K | $15.99 | -$175.94K | SELL | -1.19% | 916.08K | Nov 16 - Nov 17 | View |
| Oct 26, 2010 | Roy A Whitfield | DIRECTOR | -34.25K | $16.97 | -$581.25K | SELL | -3.56% | 927.08K | Oct 22 - Oct 25 | View |
| Sep 23, 2010 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | -32.15K | $14.88 | -$478.32K | SELL | -11.92% | 237.50K | Sep 21 - Sep 23 | View |
| Sep 23, 2010 | Baker Biotech Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | -397.05K | $14.88 | -$5.91M | SELL | -11.92% | 2.93M | Sep 21 - Sep 23 | View |
| Sep 23, 2010 | Baker Bros Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | -32.39K | $14.88 | -$481.83K | SELL | -11.92% | 239.26K | Sep 21 - Sep 23 | View |
| Sep 23, 2010 | Baker Tisch Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | -21.62K | $14.88 | -$321.68K | SELL | -11.92% | 159.74K | Sep 21 - Sep 23 | View |
| Sep 23, 2010 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | -1.02M | $14.88 | -$15.13M | SELL | -11.92% | 7.51M | Sep 21 - Sep 23 | View |
| Aug 11, 2010 | Baker Bros Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | -12.80K | $14.06 | -$180.07K | SELL | -4.50% | 271.65K | Aug 09 - Aug 10 | View |
| Aug 11, 2010 | Baker Tisch Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | -8.55K | $14.06 | -$120.21K | SELL | -4.50% | 181.36K | Aug 09 - Aug 10 | View |
| Aug 11, 2010 | Baker Biotech Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | -156.93K | $14.06 | -$2.21M | SELL | -4.50% | 3.33M | Aug 09 - Aug 10 | View |
| Aug 11, 2010 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | -401.87K | $14.06 | -$5.65M | SELL | -4.50% | 8.53M | Aug 09 - Aug 10 | View |
| Aug 11, 2010 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | -12.71K | $14.07 | -$178.70K | SELL | -4.50% | 269.65K | Aug 09 - Aug 10 | View |
| Aug 10, 2010 | Patricia A Schreck | EVP, GENERAL COUNSEL | 0.00 | $10.02 | -$734.25K | SELL-OPTIONS | 0.00% | 4.50K | Aug 06 | View |
| Aug 10, 2010 | Laurent Chardonnet | — | -15.62K | $14.06 | -$219.53K | SELL | -74.51% | 5.34K | Aug 09 | View |
| Jul 06, 2010 | David C Hastings | CHIEF FINANCIAL OFFICER | 2.00K | $10.24 | $20.48K | BUY | 30.77% | 8.50K | Jul 01 | View |
| Jul 06, 2010 | Paul A Friedman | CHIEF EXECUTIVE OFFICER | 10.00K | $10.43 | $104.26K | BUY | 3.93% | 264.56K | Jul 01 | View |
| Jun 21, 2010 | Paula Swain | EVP, HUMAN RESOURCES | 0.00 | $9.60 | -$695.54K | SELL-OPTIONS | 0.00% | 0.00 | Jun 17 | View |
| Mar 17, 2010 | Richard S Levy | EVP, CHIEF DRUG DEV&MEDICAL OF | 0.00 | $8.56 | -$175.00K | SELL-OPTIONS | 0.00% | 0.00 | Mar 15 | View |
| Jan 08, 2010 | Steven M Friedman | EVP, BIOLOGY & PRECLINICAL DEV | -22.00K | $10.90 | -$239.80K | SELL | -36.58% | 38.14K | Jan 08 | View |
| Mar 10, 2009 | Paul A Friedman | CHIEF EXECUTIVE OFFICER | 20.00K | $2.10 | $42.00K | BUY | 8.53% | 254.56K | Mar 06 - Mar 09 | View |
| Mar 05, 2009 | Baker Tisch Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 162.00 | $2.15 | $347.96 | BUY | 0.12% | 139.62K | Mar 03 - Mar 05 | View |
| Mar 05, 2009 | Baker Biotech Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 3.45K | $2.15 | $7.40K | BUY | 0.10% | 3.49M | Mar 03 - Mar 05 | View |
| Mar 05, 2009 | Baker Bros Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 10.00 | $2.15 | $21.50 | BUY | 0.00% | 284.45K | Mar 03 - Mar 05 | View |
| Mar 05, 2009 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 20.76K | $2.15 | $44.63K | BUY | 0.29% | 7.08M | Mar 03 - Mar 05 | View |
| Mar 05, 2009 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 576.00 | $2.15 | $1.24K | BUY | 0.32% | 180.85K | Mar 03 - Mar 05 | View |
| Mar 05, 2009 | Paul A Friedman | CHIEF EXECUTIVE OFFICER | 20.00K | $2.20 | $44.00K | BUY | 9.32% | 234.56K | Mar 03 - Mar 05 | View |
| Mar 02, 2009 | Baker Bros Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 17.00 | $2.15 | $36.60 | BUY | 0.01% | 284.44K | Mar 02 | View |
| Mar 02, 2009 | Baker Tisch Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 343.00 | $2.15 | $738.46 | BUY | 0.25% | 139.45K | Mar 02 | View |
| Mar 02, 2009 | Baker Biotech Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 7.70K | $2.15 | $16.58K | BUY | 0.22% | 3.48M | Mar 02 | View |
| Mar 02, 2009 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 927.00 | $2.15 | $2.00K | BUY | 0.52% | 180.27K | Mar 02 | View |
| Mar 02, 2009 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 33.36K | $2.15 | $71.83K | BUY | 0.47% | 7.06M | Mar 02 | View |
| Dec 19, 2008 | Baker Biotech Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 227.27K | $3.50 | $796.55K | BUY | 7.00% | 3.48M | Dec 17 - Dec 19 | View |
| Dec 19, 2008 | Baker Bros Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 1.90K | $3.55 | $6.73K | BUY | 0.67% | 285.48K | Dec 17 - Dec 19 | View |
| Dec 19, 2008 | Baker Tisch Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 5.06K | $3.51 | $17.73K | BUY | 3.77% | 139.11K | Dec 17 - Dec 19 | View |
| Dec 19, 2008 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 735.33K | $3.51 | $2.58M | BUY | 11.69% | 7.03M | Dec 17 - Dec 19 | View |
| Dec 19, 2008 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 20.09K | $3.51 | $70.41K | BUY | 12.61% | 179.34K | Dec 17 - Dec 19 | View |
| Nov 24, 2008 | Brian W Metcalf | CHIEF DRUG DISCOVERY SCIENTIST | 5.00K | $2.19 | $10.95K | BUY | 11.15% | 49.84K | Nov 21 | View |
| Nov 21, 2008 | Laurent Chardonnet | — | 8.00K | $2.71 | $21.68K | BUY | 3200.00% | 8.25K | Nov 20 | View |
| Nov 21, 2008 | David C Hastings | CHIEF FINANCIAL OFFICER | 4.00K | $2.36 | $9.44K | BUY | 160.00% | 6.50K | Nov 20 | View |
| Nov 21, 2008 | Patricia Schreck | EVP, GENERAL COUNSEL | 2.50K | $2.44 | $6.10K | BUY | 125.00% | 4.50K | Nov 20 | View |
| Nov 21, 2008 | Paul A Friedman | CHIEF EXECUTIVE OFFICER | 13.00K | $2.55 | $33.15K | BUY | 6.45% | 214.56K | Nov 20 | View |
| Oct 16, 2008 | Paul A Friedman | CHIEF EXECUTIVE OFFICER | 10.00K | $4.95 | $49.51K | BUY | 5.22% | 201.56K | Oct 14 - Oct 15 | View |
| Aug 05, 2008 | Baker Biotech Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 201.65K | $9.00 | $1.81M | BUY | 6.62% | 3.25M | Jul 31 | View |
| Aug 05, 2008 | Baker Bros Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 1.54K | $9.00 | $13.85K | BUY | 0.55% | 283.58K | Jul 31 | View |
| Aug 05, 2008 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 864.09K | $9.00 | $7.78M | BUY | 15.92% | 6.29M | Jul 31 | View |
| Aug 05, 2008 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 27.72K | $9.00 | $249.52K | BUY | 21.08% | 159.26K | Jul 31 | View |
| Aug 05, 2008 | Baker Tisch Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 5.00K | $9.00 | $44.97K | BUY | 3.87% | 134.05K | Jul 31 | View |
| Jan 24, 2008 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 7.00 | $10.62 | $74.34 | BUY | 0.01% | 131.53K | Jan 22 | View |
| Jan 24, 2008 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 223.00 | $10.62 | $2.37K | BUY | 0.00% | 5.43M | Jan 22 | View |
| Jan 24, 2008 | Baker Biotech Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 65.00 | $10.62 | $690.30 | BUY | 0.00% | 3.05M | Jan 22 | View |
| Jan 24, 2008 | Baker Tisch Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 4.00 | $10.62 | $42.48 | BUY | 0.00% | 129.06K | Jan 22 | View |
| Jan 24, 2008 | Baker Bros Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 1.00 | $10.62 | $10.62 | BUY | 0.00% | 282.04K | Jan 22 | View |
| Jan 16, 2008 | Baker Bros Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 94.00 | $10.99 | $1.03K | BUY | 0.03% | 282.04K | Jan 14 | View |
| Jan 16, 2008 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 34.62K | $10.99 | $380.40K | BUY | 0.64% | 5.43M | Jan 14 | View |
| Jan 16, 2008 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 1.10K | $10.99 | $12.10K | BUY | 0.84% | 131.53K | Jan 14 | View |
| Jan 16, 2008 | Baker Biotech Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 13.68K | $10.99 | $150.25K | BUY | 0.45% | 3.05M | Jan 14 | View |
| Jan 16, 2008 | Baker Tisch Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 723.00 | $10.99 | $7.94K | BUY | 0.56% | 129.05K | Jan 14 | View |
| Jan 11, 2008 | Baker Bros Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 334.00 | $10.94 | $3.65K | BUY | 0.12% | 281.95K | Jan 09 - Jan 11 | View |
| Jan 11, 2008 | Baker Biotech Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 48.39K | $10.94 | $529.51K | BUY | 1.62% | 3.03M | Jan 09 - Jan 11 | View |
| Jan 11, 2008 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 122.51K | $10.94 | $1.34M | BUY | 2.32% | 5.39M | Jan 09 - Jan 11 | View |
| Jan 11, 2008 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 3.89K | $10.94 | $42.57K | BUY | 3.08% | 130.43K | Jan 09 - Jan 11 | View |
| Jan 11, 2008 | Baker Tisch Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 2.56K | $10.94 | $28.00K | BUY | 2.03% | 128.33K | Jan 09 - Jan 11 | View |
| Jan 08, 2008 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 993.83K | $10.14 | $10.08M | BUY | 23.24% | 5.27M | Jan 04 - Jan 08 | View |
| Jan 08, 2008 | capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 31.57K | $10.14 | $320.19K | BUY | 33.25% | 126.53K | Jan 04 - Jan 08 | View |
| Jan 08, 2008 | Baker Biotech Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 392.57K | $10.14 | $3.98M | BUY | 15.14% | 2.98M | Jan 04 - Jan 08 | View |
| Jan 08, 2008 | Baker Tisch Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 20.75K | $10.14 | $210.42K | BUY | 19.76% | 125.77K | Jan 04 - Jan 08 | View |
| Jan 08, 2008 | Baker Bros Capital GP LLCJULIAN BAKERFELIX BAKER | DIRECTOR | 2.71K | $10.14 | $27.50K | BUY | 0.97% | 281.62K | Jan 04 - Jan 08 | View |
| Dec 19, 2007 | Baker Tisch Capital GP LLCJULIAN BAKER | DIRECTOR | 4.96K | $10.60 | $52.56K | BUY | 4.96% | 105.02K | Dec 17 - Dec 19 | View |
| Dec 19, 2007 | Baker Bros Capital GP LLCJULIAN BAKER | DIRECTOR | 648.00 | $10.60 | $6.87K | BUY | 0.23% | 278.90K | Dec 17 - Dec 19 | View |
| Dec 19, 2007 | Baker Biotech Capital GP LLCJULIAN BAKER | DIRECTOR | 93.85K | $10.60 | $994.55K | BUY | 3.76% | 2.59M | Dec 17 - Dec 19 | View |
| Dec 19, 2007 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKER | DIRECTOR | 237.59K | $10.60 | $2.52M | BUY | 5.88% | 4.28M | Dec 17 - Dec 19 | View |
| Dec 19, 2007 | capital GP LLCJULIAN BAKER | DIRECTOR | 7.55K | $10.60 | $80.00K | BUY | 8.64% | 94.96K | Dec 17 - Dec 19 | View |
| Dec 12, 2007 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKER | DIRECTOR | 433.42K | $9.99 | $4.33M | BUY | 12.02% | 4.04M | Dec 10 - Dec 12 | View |
| Dec 12, 2007 | capital GP LLCJULIAN BAKER | DIRECTOR | 13.77K | $9.99 | $137.53K | BUY | 18.70% | 87.41K | Dec 10 - Dec 12 | View |
| Dec 12, 2007 | Baker Bros Capital GP LLCJULIAN BAKER | DIRECTOR | 1.18K | $9.99 | $11.82K | BUY | 0.43% | 278.25K | Dec 10 - Dec 12 | View |
| Dec 12, 2007 | Baker Biotech Capital GP LLCJULIAN BAKER | DIRECTOR | 171.20K | $9.99 | $1.71M | BUY | 7.36% | 2.50M | Dec 10 - Dec 12 | View |
| Dec 12, 2007 | Baker Tisch Capital GP LLCJULIAN BAKER | DIRECTOR | 9.05K | $9.99 | $90.39K | BUY | 9.94% | 100.06K | Dec 10 - Dec 12 | View |
| Dec 06, 2007 | Baker Tisch Capital GP LLCJULIAN BAKER | DIRECTOR | 1.14K | $8.98 | $10.23K | BUY | 1.27% | 91.01K | Dec 04 | View |
| Dec 06, 2007 | Baker Biotech Capital GP LLCJULIAN BAKER | DIRECTOR | 19.59K | $8.98 | $175.98K | BUY | 0.85% | 2.33M | Dec 04 | View |
| Dec 06, 2007 | capital GP LLCJULIAN BAKER | DIRECTOR | 1.81K | $8.98 | $16.28K | BUY | 2.52% | 73.64K | Dec 04 | View |
| Dec 06, 2007 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKER | DIRECTOR | 57.30K | $8.98 | $514.68K | BUY | 1.61% | 3.61M | Dec 04 | View |
| Dec 06, 2007 | Baker Bros Capital GP LLCJULIAN BAKER | DIRECTOR | 153.00 | $8.98 | $1.37K | BUY | 0.06% | 277.07K | Dec 04 | View |
| Dec 03, 2007 | Baker Biotech Capital GP LLCJULIAN BAKER | DIRECTOR | 17.13K | $8.68 | $148.70K | BUY | 0.75% | 2.31M | Nov 29 - Dec 03 | View |
| Dec 03, 2007 | capital GP LLCJULIAN BAKER | DIRECTOR | 3.04K | $8.68 | $26.41K | BUY | 4.42% | 71.83K | Nov 29 - Dec 03 | View |
| Dec 03, 2007 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKER | DIRECTOR | 96.31K | $8.68 | $836.04K | BUY | 2.79% | 3.55M | Nov 29 - Dec 03 | View |
| Dec 03, 2007 | Baker Bros Capital GP LLCJULIAN BAKER | DIRECTOR | 258.00 | $8.68 | $2.24K | BUY | 0.09% | 276.92K | Nov 29 - Dec 03 | View |
| Nov 28, 2007 | Baker Bros Capital GP LLCJULIAN BAKER | DIRECTOR | 1.10K | $8.11 | $8.94K | BUY | 0.40% | 276.66K | Nov 26 - Nov 28 | View |
| Nov 28, 2007 | Baker Biotech Capital GP LLCJULIAN BAKER | DIRECTOR | 73.26K | $8.11 | $594.06K | BUY | 3.30% | 2.29M | Nov 26 - Nov 28 | View |
| Nov 28, 2007 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKER | DIRECTOR | 411.94K | $8.11 | $3.34M | BUY | 13.55% | 3.45M | Nov 26 - Nov 28 | View |
| Nov 28, 2007 | capital GP LLCJULIAN BAKER | DIRECTOR | 13.02K | $8.11 | $105.57K | BUY | 23.34% | 68.79K | Nov 26 - Nov 28 | View |
| Nov 21, 2007 | Baker Biotech Capital GP LLCJULIAN BAKER | DIRECTOR | 70.74K | $8.18 | $579.01K | BUY | 3.30% | 2.22M | Nov 19 - Nov 21 | View |
| Nov 21, 2007 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKER | DIRECTOR | 278.91K | $8.17 | $2.28M | BUY | 10.10% | 3.04M | Nov 19 - Nov 21 | View |
| Nov 21, 2007 | capital GP LLCJULIAN BAKER | DIRECTOR | 8.81K | $8.17 | $72.00K | BUY | 18.77% | 55.77K | Nov 19 - Nov 21 | View |
| Nov 21, 2007 | Baker Bros Capital GP LLCJULIAN BAKER | DIRECTOR | 747.00 | $8.17 | $6.10K | BUY | 0.27% | 275.56K | Nov 19 - Nov 21 | View |
| Nov 21, 2007 | Baker Tisch Capital GP LLCJULIAN BAKER | DIRECTOR | 318.00 | $8.22 | $2.62K | BUY | 0.36% | 89.87K | Nov 19 | View |
| Nov 16, 2007 | capital GP LLCJULIAN BAKER | DIRECTOR | 10.66K | $8.49 | $90.54K | BUY | 29.38% | 46.95K | Nov 14 - Nov 16 | View |
| Nov 16, 2007 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKER | DIRECTOR | 337.46K | $8.49 | $2.87M | BUY | 13.92% | 2.76M | Nov 14 - Nov 16 | View |
| Nov 16, 2007 | Baker Biotech Capital GP LLCJULIAN BAKER | DIRECTOR | 126.10K | $8.50 | $1.07M | BUY | 6.24% | 2.15M | Nov 14 - Nov 16 | View |
| Nov 16, 2007 | Baker Bros Capital GP LLCJULIAN BAKER | DIRECTOR | 904.00 | $8.49 | $7.68K | BUY | 0.33% | 274.81K | Nov 14 - Nov 16 | View |
| Nov 13, 2007 | Baker Tisch Capital GP LLCJULIAN BAKER | DIRECTOR | 2.44K | $8.09 | $19.75K | BUY | 2.84% | 88.50K | Nov 09 - Nov 13 | View |
| Nov 13, 2007 | capital GP LLCJULIAN BAKER | DIRECTOR | 21.93K | $8.09 | $177.29K | BUY | 152.63% | 36.29K | Nov 09 - Nov 13 | View |
| Nov 13, 2007 | Baker Biotech Capital GP LLCJULIAN BAKER | DIRECTOR | 274.18K | $8.09 | $2.22M | BUY | 15.70% | 2.02M | Nov 09 - Nov 13 | View |
| Nov 13, 2007 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKER | DIRECTOR | 693.77K | $8.09 | $5.61M | BUY | 40.10% | 2.42M | Nov 09 - Nov 13 | View |
| Nov 13, 2007 | Baker Bros Capital GP LLCJULIAN BAKER | DIRECTOR | 1.86K | $8.09 | $15.02K | BUY | 0.68% | 273.91K | Nov 09 - Nov 13 | View |
| Aug 20, 2007 | Paul A Friedman | CHIEF EXECUTIVE OFFICER | 16.66K | $5.47 | $91.16K | BUY | 9.53% | 191.56K | Aug 17 | View |
| Aug 03, 2007 | Baker Biotech Capital GP LLCJULIAN BAKER | DIRECTOR | 171.33K | $4.91 | $840.55K | BUY | 10.88% | 1.75M | Aug 01 - Aug 03 | View |
| Aug 03, 2007 | Baker Brothers Life Sciences Capital GP LLCJULIAN BAKER | DIRECTOR | 451.86K | $4.91 | $2.22M | BUY | 35.35% | 1.73M | Aug 01 - Aug 03 | View |
| Aug 03, 2007 | Baker Bros Capital GP LLCJULIAN BAKER | DIRECTOR | 1.15K | $4.91 | $5.65K | BUY | 0.42% | 272.05K | Aug 01 - Aug 03 | View |
| Aug 03, 2007 | capital GP LLCJULIAN BAKER | DIRECTOR | 14.37K | $4.91 | $70.47K | BUY | ∞ | 14.37K | Aug 01 - Aug 03 | View |
| Feb 13, 2007 | Brian W Metcalf | CHIEF DRUG DISCOVERY SCIENTIST | 5.00K | $3.88 | $19.42K | BUY | 17.92% | 32.91K | Apr 17 | View |
| Apr 07, 2006 | Paula Swain | EVP, HUMAN RESOURCES | 3.00K | $3.65 | $10.95K | BUY | 19.92% | 18.06K | Apr 06 | View |
| Apr 05, 2006 | Paul A Friedman | CHIEF EXECUTIVE OFFICER | 5.50K | $3.56 | $19.58K | BUY | 3.25% | 174.90K | Apr 04 | View |
| Apr 05, 2006 | David C Hastings | CHIEF FINANCIAL OFFICER | 2.50K | $3.60 | $9.00K | BUY | ∞ | 2.50K | Apr 04 | View |
| Apr 05, 2006 | Patricia Schreck | EVP, GENERAL COUNSEL | 2.00K | $3.59 | $7.18K | BUY | ∞ | 2.00K | Apr 04 | View |
| Aug 23, 2005 | Paul A Friedman | CHIEF EXECUTIVE OFFICER | 2.70K | $7.24 | $19.56K | BUY | 2.31% | 119.40K | Aug 23 | View |
| Mar 10, 2005 | Richard U. DeSchutter | DIRECTOR | 20.00K | $7.05 | $140.95K | BUY | 400.00% | 25.00K | Mar 09 | View |
| Nov 04, 2004 | Julian Baker | DIRECTOR | 300.00K | $9.75 | $2.92M | BUY | ∞ | 30.94K | Nov 01 | View |
| Sep 13, 2004 | Paul A Brooke | DIRECTOR | 100.00K | $7.74 | $774.00K | BUY | 201.68% | 149.58K | Sep 09 | View |
| Aug 17, 2004 | Paul A Friedman | CHIEF EXECUTIVE OFFICER | 3.50K | $5.62 | $19.66K | BUY | 0.84% | 421.13K | Aug 16 | View |
| Aug 13, 2004 | Daniel R Tisch | 10% OWNER | 255.75K | $5.50 | $1.41M | BUY | 23.71% | 1.33M | Aug 12 | View |
| Aug 13, 2004 | Andrew H Tisch | 10% OWNER | 255.75K | $5.50 | $1.41M | BUY | 23.71% | 1.33M | Aug 12 | View |
| Aug 13, 2004 | James S Tisch | 10% OWNER | 255.75K | $5.50 | $1.41M | BUY | 23.71% | 1.33M | Aug 12 | View |
| Aug 13, 2004 | Thomas J Tisch | 10% OWNER | 255.75K | $5.50 | $1.41M | BUY | 20.00% | 1.53M | Aug 12 | View |
| Sep 24, 2003 | BAKER BROS CAPITAL GP LLCJULIAN BAKERFELIX BAKER | 10% OWNER | 13.80K | $4.97 | $68.59K | BUY | 5.53% | 263.50K | Sep 22 | View |
| Sep 24, 2003 | BAKER BIOTECH CAPITAL II GP LLCJULIAN BAKERFELIX BAKER | 10% OWNER | 71.10K | $4.97 | $353.40K | BUY | 6.97% | 1.09M | Sep 22 | View |
| Sep 24, 2003 | BAKER BIOTECH CAPITAL GP LLCJULIAN BAKERFELIX BAKER | 10% OWNER | 67.30K | $4.97 | $334.51K | BUY | 4.76% | 1.48M | Sep 22 | View |
| Sep 23, 2003 | BAKER BROS CAPITAL GP LLCJULIAN BAKERFELIX BAKER | 10% OWNER | 107.65K | $5.04 | $542.28K | BUY | 75.78% | 249.70K | Sep 19 | View |
| Sep 23, 2003 | BAKER BIOTECH CAPITAL GP LLCJULIAN BAKERFELIX BAKER | 10% OWNER | 526.00K | $5.04 | $2.65M | BUY | 59.31% | 1.41M | Sep 19 | View |
| Sep 23, 2003 | BAKER BIOTECH CAPITAL II GP LLCJULIAN BAKERFELIX BAKER | 10% OWNER | 556.35K | $5.04 | $2.80M | BUY | 119.91% | 1.02M | Sep 19 | View |